Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.

Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37374661

about

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.Incidence of Vertebral Fractures in Women with Systemic Lupus Erythematosus After 8 Years of Follow-Up.Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro.Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.Evolve osteoporosis and other guidelines avoiding cognitive bias.

P2860

Q27314920-D6776858-46CC-4831-9260-B140DC89464D Q30843177-7ABDFF99-2134-4F5A-845F-0C8C121C1955 Q36343783-E8FF4192-4723-41DF-A158-555843080B1F Q38784224-385FBF01-877D-4154-A6AD-54B2857ECDA7 Q41115921-D75517AE-047F-49E3-B12D-03B0C2DCE4AB Q47771776-EE94E6D0-D3C4-4472-9174-FC8F855D4A48 Q47952057-A431B31C-E1E6-468A-A3D2-EE178605D478 Q53221347-1573F6C6-7BE9-40C3-9F32-C46BA08F0976

P2860

Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37374661

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bisphosphonates for the preven ...... atic review and meta-analysis.

@en

Bisphosphonates for the preven ...... atic review and meta-analysis.

@nl

type

label

Bisphosphonates for the preven ...... atic review and meta-analysis.

@en

Bisphosphonates for the preven ...... atic review and meta-analysis.

@nl

prefLabel

Bisphosphonates for the preven ...... atic review and meta-analysis.

@en

Bisphosphonates for the preven ...... atic review and meta-analysis.

@nl

P1433

Q37374661-4A375DF7-4EE1-4DD3-98D6-93EEDA2D38CD

P1476

Q37374661-4FAFBD42-9601-427A-BB62-D1498728E5C8

P2093

Q37374661-03F1FF75-0612-4CEA-AAEB-660DD272BF3C

Q37374661-3DF1C360-C824-4DC9-8B6A-9D90A855B5EB

Q37374661-6408A060-7373-4147-B1D2-F440A5AB2DDB

Q37374661-996164CF-1AED-47BE-A9FF-4FA9D0146539

Q37374661-CC696628-A569-4ACA-AB1B-D3E3FE929C30

P275

Q37374661-29B0F209-A474-460A-9C53-1E8F8874C72D

P2860

Q37374661-06BC66F0-FF32-49CC-9B20-5116104E650B

Q37374661-081A7718-1594-4221-BB68-EAADED288F74

Q37374661-15A5615D-AB4A-4B99-B309-CC13C103D612

Q37374661-1914C216-2EC8-4FAF-B08E-793B230A79BE

Q37374661-19AED817-5D63-4D42-9A35-AAB75FBB8135

Q37374661-271E3BC6-7B7A-418A-96D2-E309C23285F2

Q37374661-3281CF5C-75F4-4E4C-B410-93D295C92E5F

Q37374661-3393AD25-6AAB-432C-BC30-C9DD4128B754

Q37374661-458882F4-56D3-4D82-BF07-FCCCF400B723

Q37374661-45C5A26B-771E-4B6B-AAEB-05120D060E4C

P304

Q37374661-4FD28F6E-257B-46B6-86C7-A2FEC2CEB6B3

P31

Q37374661-7D6C746F-C0DC-427D-832F-552E3089AA42

Q37374661-9887EB0A-C1D0-44FB-A6E9-9453D0CA6926

Q37374661-a806cd72-ef41-4041-be1f-07d659fbc394

P356

Q37374661-EFEEB8F7-3AE5-4490-8681-F120DCF28C7D

P407

Q37374661-23AFFBCE-5998-4144-AA5C-9C4A350AEF63

P433

Q37374661-9EBDCC33-3823-4C39-A56E-472A2BD969CB

P478

Q37374661-ABF76800-DFE4-4442-87A8-B48C0771A59A

P5008

Q37374661-2C4F78B1-3CF2-494E-A98E-2085014595C6

P577

Q37374661-B4487758-74E8-458D-BB5F-2B3DA435A4AE

P5875

Q37374661-788A73AA-767D-43FC-8E3E-D9972E4EDF08

P698

Q37374661-0790DE48-DA11-4787-94CD-E86EA59C5618

P921

Q37374661-3B307CA1-7A04-40E1-B167-8885BD5095E6

Q37374661-B8E5C8EF-4F57-471D-837A-707806DAA74A

Q37374661-EBD22375-2169-42EE-ACCC-46A114067FD6

Q37374661-EF30D964-188B-4133-9BB0-3CCCE4731B8F

P932

Q37374661-D4933063-3D90-437E-BE15-74D2CB36DE71

P356

JOURNAL.PONE.0080890

P1433

P1476

Bisphosphonates for the preven ...... atic review and meta-analysis.

@en

P2093

Shumei Zeng

http://www.w3.org/2001/XMLSchema#string

Yue Wang

http://www.w3.org/2001/XMLSchema#string

Zhiyun Feng

http://www.w3.org/2001/XMLSchema#string

Zhiyun Zheng

http://www.w3.org/2001/XMLSchema#string

Zhong Chen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

Bone mass in patients with rheumatoid arthritis.

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.

Developments in the therapeutic applications of bisphosphonates.

Bisphosphonates for steroid induced osteoporosis.

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.

Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.

P304

e80890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0080890

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259269090

http://www.w3.org/2001/XMLSchema#string

P698

24324644

http://www.w3.org/2001/XMLSchema#string

P921

organophosphorus compound

postmenopausal osteoporosis

human musculoskeletal system

P932

3855695

http://www.w3.org/2001/XMLSchema#string